LEI-101 - CAS 1228660-00-1

LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC50 of 8 for hCB2, and a pKi of less than 4 for hERG. LEI-101 is approximately 100-fold more potent in binding to CB2 receptors than to CB1 receptors. It has therapeutic potential in diseases associated with inflammation and/or oxidative stress, including kidney disease [1] [2].

Others, Cannabinoid Receptor

GPCR/G Protein, Others

1228660-00-1

C23H25FN4O4S

472.53

O=C1N(C(=O)CN1CC2=CC=C(C=C2)C=3N=C(CN4CCS(=O)(=O)CC4)C(F)=CC3)C5CC5

-20°C

Ice Packs

Small Compound